Arcutis Biotherapeutics Inc
NASDAQ:ARQT

Watchlist Manager
Arcutis Biotherapeutics Inc Logo
Arcutis Biotherapeutics Inc
NASDAQ:ARQT
Watchlist
Price: 25.61 USD -2.73% Market Closed
Market Cap: $3.1B

Wall Street
Price Targets

ARQT Price Targets Summary
Arcutis Biotherapeutics Inc

Wall Street analysts forecast ARQT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ARQT is 32.26 USD with a low forecast of 29.29 USD and a high forecast of 38.85 USD.

Lowest
Price Target
29.29 USD
14% Upside
Average
Price Target
32.26 USD
26% Upside
Highest
Price Target
38.85 USD
52% Upside
Arcutis Biotherapeutics Inc Competitors:
Price Targets
ZEAL
Zealand Pharma A/S
73% Upside
SMCP
SMCP SA
29% Upside
ACAD
ACADIA Pharmaceuticals Inc
19% Upside

Revenue
Forecast

N/A
Past Growth
41% / Year
Estimated Growth
Estimates Accuracy
4%
Average Beat
N/A
Past Growth
41% / Year
Estimated Growth
Estimates Accuracy
4%
Average Beat

The compound annual growth rate of Arcutis Biotherapeutics Inc's revenue for the next 4 years is 41%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-5%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-5%
Average Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-59%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-59%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ARQT's stock price target?
Price Target
32.26 USD

According to Wall Street analysts, the average 1-year price target for ARQT is 32.26 USD with a low forecast of 29.29 USD and a high forecast of 38.85 USD.

What is Arcutis Biotherapeutics Inc's Revenue forecast?
Projected CAGR
41%

The compound annual growth rate of Arcutis Biotherapeutics Inc's revenue for the next 4 years is 41%.

Back to Top